← Eichor
Condition: Psma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Psma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.
Phase 2 · 1 location(s) · IRCCS San Raffaele · NCT06305390A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
Phase 1 · 6 location(s) · Janssen Research & Development, LLC · NCT07082920Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
EARLY_Phase 1 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07164027Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Functio
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT07169825PSMA in Gastroenterologic Tumors (GIPSMA)
NA · 1 location(s) · Wuerzburg University Hospital · NCT05547919Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)
Phase 2 · 2 location(s) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRS · NCT05893381Breast Cancer PSMA PET
EARLY_Phase 1 · 1 location(s) · Ahmad Shariftabrizi · NCT06586047Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical
Phase 2 · 1 location(s) · Marco Oderda · NCT06758882A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Phase 1 · 16 location(s) · Janssen Research & Development, LLC · NCT06095089Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease
NA · 1 location(s) · British Columbia Cancer Agency · NCT03836196Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Canc
Phase 1 · 2 location(s) · Weill Medical College of Cornell University · NCT04886986Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)
NA · 1 location(s) · Martini-Klinik am UKE GmbH · NCT04271579Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Phase 1 · 2 location(s) · Brigham and Women's Hospital · NCT06062745Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Phase 3 · 88 location(s) · Novartis Pharmaceuticals · NCT06855277Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer
EARLY_Phase 1 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07156045Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients
NA · 1 location(s) · Canisius-Wilhelmina Hospital · NCT05000827Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT06353321Large Language Model-Assisted cTNM Annotation From Chinese PSMA PET/CT Reports
Phase N/A · 1 location(s) · First Affiliated Hospital of Wenzhou Medical University · NCT07707232Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Phase 1/Phase 2 · 35 location(s) · AstraZeneca · NCT07590934Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
Phase 4 · 2 location(s) · Brigham and Women's Hospital · NCT06099093Clinical Evaluation of 177Lu-PSMA-VG01 Injection in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate
Phase 1 · 1 location(s) · VitsGen Therapeutics Inc. · NCT07660211PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostat
Phase 2/Phase 3 · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07426055An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
EARLY_Phase 1 · 1 location(s) · Northwestern University · NCT06813898Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recu
Phase 2 · 1 location(s) · St Vincent's Hospital, Sydney · NCT06907641The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
Phase 1 · 2 location(s) · Memorial Sloan Kettering Cancer Center · NCT04167969PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer
Phase 3 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT03594760Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance
NA · 4 location(s) · Weill Medical College of Cornell University · NCT0594865724 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer
NA · 1 location(s) · IRCCS San Raffaele · NCT05936736High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT03327675Preoperative Planning With PSMA-PET in Melanoma Surgery Trial
Phase 2 · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT06560905
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.